Literature DB >> 2774774

Diabetes and hypertension. Blood pressure in clinical diabetic patients and a control population.

A Teuscher1, M Egger, J B Herman.   

Abstract

Blood pressure was recorded in a group of 514 randomly selected Swiss diabetic patients (267 men and 247 women; 164 early-onset and 350 late-onset diabetics) aged from 35 to 54 years. These patients were compared with a control group from a population survey in Switzerland (877 men and 850 women). Mean systolic pressure (+/- SD) in the diabetic population was 139.3 +/- 21 mm Hg as compared with 125.5 +/- 17 mm Hg among controls. Mean diastolic pressure was 85.4 +/- 12 mm Hg in diabetic subjects as compared with 79.1 +/- 12 mm Hg in controls. The difference was reduced by about 25% after adjustment for body mass, age, and sex; 30.7% of diabetic subjects as compared with 8.2% among controls were hypertensive. Sixty-two percent of the hypertensive diabetic patients and 45% of the hypertensive controls were receiving antihypertensive treatment. In a multivariate analysis, presence of proteinuria and larger body mass had an important influence on systolic and diastolic blood pressures and the risk of hypertension. Diabetes duration had a significant influence only on systolic blood pressure. Efforts are needed in the clinical and research field to limit and clarify the harmful effects of elevated blood pressure in diabetes.

Entities:  

Mesh:

Year:  1989        PMID: 2774774     DOI: 10.1001/archinte.149.9.1942

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  13 in total

1.  [Cardial target-organ damage in diabetes].

Authors:  W Motz; W Kerner
Journal:  Internist (Berl)       Date:  2011-05       Impact factor: 0.743

2.  Hypertension and non-insulin dependent diabetes.

Authors:  J S Yudkin
Journal:  BMJ       Date:  1991-09-28

Review 3.  Alterations in cardiac structure and function in hypertension.

Authors:  Mário Santos; Amil M Shah
Journal:  Curr Hypertens Rep       Date:  2014-05       Impact factor: 5.369

4.  Enhanced hemodynamic responses to angiotensin II in diabetes are associated with increased expression and activity of AT1 receptors in the afferent arteriole.

Authors:  Jie Zhang; Helena Y Qu; Jiangping Song; Jin Wei; Shan Jiang; Lei Wang; Liqing Wang; Jacentha Buggs; Ruisheng Liu
Journal:  Physiol Genomics       Date:  2017-08-25       Impact factor: 3.107

Review 5.  The diabetic patient with hypertension.

Authors:  G P Leese; M W Savage; P D Chattington; J P Vora
Journal:  Postgrad Med J       Date:  1996-05       Impact factor: 2.401

6.  GLP-1 receptor stimulation depresses heart rate variability and inhibits neurotransmission to cardiac vagal neurons.

Authors:  Kathleen J Griffioen; Ruiqian Wan; Eitan Okun; Xin Wang; Mary Rachael Lovett-Barr; Yazhou Li; Mohamed R Mughal; David Mendelowitz; Mark P Mattson
Journal:  Cardiovasc Res       Date:  2010-08-24       Impact factor: 10.787

7.  Ultrastructural alterations in capillaries of the diabetic hypertensive rat retina: protective effects of ACE inhibition.

Authors:  A A Dosso; E Rungger-Brändle; P M Leuenberger
Journal:  Diabetologia       Date:  2004-07-09       Impact factor: 10.122

Review 8.  Clinical practice guidelines for treatment of diabetes mellitus. Expert Committee of the Canadian Diabetes Advisory Board.

Authors: 
Journal:  CMAJ       Date:  1992-09-01       Impact factor: 8.262

9.  [ESC/EASD joint guidelines on diabetes and cardiovascular diseases].

Authors:  Wolfgang Motz; Rolf Dörr
Journal:  Herz       Date:  2009-02       Impact factor: 1.443

10.  The use of hypoglycaemic and cardiovascular drugs in 582 patients with diabetes mellitus. Description and quality assessment.

Authors:  G Van den Brink; R R Schwartzenberg; L J Hoeve; A J Porsius; L L Hoeve
Journal:  Pharm World Sci       Date:  1993-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.